{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:52:44Z","timestamp":1790538764324,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.mehy.2015.05.016","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:59:19Z","timestamp":1433465959000},"page":"298-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations"],"prefix":"10.1016","volume":"85","author":[{"given":"Giacomo","family":"Colletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Dalmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Moneghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daris","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Allevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2015.05.016_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.sempedsurg.2014.07.005","article-title":"Arteriovenous malformations","volume":"23","author":"Uller","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.mehy.2015.05.016_b0010","article-title":"Extracranial vascular anomalies (hemangiomas and vascular malformations) in children and adolescents \u2013 diagnosis, clinic and therapy","volume":"93","author":"Eivazi","year":"2014","journal-title":"Laryngorhinootologie"},{"key":"10.1016\/j.mehy.2015.05.016_b0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.joms.2013.08.008","article-title":"Contemporary management of vascular malformations","volume":"72","author":"Colletti","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.mehy.2015.05.016_b0020","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.joms.2014.02.012","article-title":"Surgical treatment of vascular malformations of the facial bones","volume":"72","author":"Colletti","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.mehy.2015.05.016_b0025","article-title":"Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenic role of the beta-adrenergic system","author":"Filippi","year":"2014","journal-title":"Med Res Rev"},{"issue":"6","key":"10.1016\/j.mehy.2015.05.016_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.mehy.2015.05.016_b0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.preteyeres.2014.06.001","article-title":"The beta-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases","volume":"42","author":"Casini","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.mehy.2015.05.016_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apt.12527","article-title":"Review article: gastrointestinal angiodysplasia \u2013 pathogenesis, diagnosis and management","volume":"39","author":"Sami","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mehy.2015.05.016_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.mehy.2013.01.031","article-title":"Pulmonary arteriovenous malformations etiologies in HHT patients and potential utility of thalidomide","volume":"80","author":"Lacout","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2015.05.016_b0050","article-title":"Norepinephrine promotes tumor microenvironment reactivity through \u03b23-adrenoreceptors during melanoma progression","author":"Calvani","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.mehy.2015.05.016_b0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10456-014-9436-3","article-title":"VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2","volume":"17","author":"Han","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.mehy.2015.05.016_b0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10620-014-3257-5","article-title":"Inhibition of endothelial Slit2\/Robo1 signaling by thalidomide restrains angiogenesis by blocking the PI3K\/Akt pathway","volume":"59","author":"Li","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mehy.2015.05.016_b0065","first-page":"1","article-title":"Concurrent thalidomide and radiation therapy for extensive arteriovenous malformations","volume":"99","author":"Blinc","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mehy.2015.05.016_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3395\/vd.v1i3.57","article-title":"Novel thalidomide analogues, \u201cme too\u201d drugs and the Brazilian law","volume":"1","author":"Paumgartten","year":"2013","journal-title":"Visa em Debate"},{"key":"10.1016\/j.mehy.2015.05.016_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1590\/0102-311XPE010414","article-title":"Thalidomide and its analogues: comparative clinical efficacy and safety and cost-effectiveness","volume":"30","author":"Paumgartten","year":"2014","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.mehy.2015.05.016_b0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1249543","article-title":"Medicine. How thalidomide works against cancer","volume":"343","author":"Stewart","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.mehy.2015.05.016_b0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/1751-2980.12009","article-title":"Successful treatment with thalidomide for a patient with recurrent gastrointestinal bleeding due to angiodysplasia diagnosed by capsule endoscopy","volume":"14","author":"Tan","year":"2013","journal-title":"J Dig Dis"},{"key":"10.1016\/j.mehy.2015.05.016_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.08.2011.4585","article-title":"Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with Thalidomide","author":"Alam","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.mehy.2015.05.016_b0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4321\/S1130-01082012000200005","article-title":"Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias","volume":"104","author":"Garrido","year":"2012","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.mehy.2015.05.016_b0100","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1592\/phco.26.7.1018","article-title":"Thalidomide-induced severe hepatotoxicity","volume":"26","author":"Hanje","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.mehy.2015.05.016_b0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1359-6446(04)03307-0","article-title":"Thalidomide as a novel therapeutic agent: new uses for an old product","volume":"10","author":"Teo","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.mehy.2015.05.016_b0110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1160\/TH06-02-0080","article-title":"Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations","volume":"95","author":"Hussein","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mehy.2015.05.016_b0115","unstructured":"The Cleveland Clinic multiple Myeloma Research Center. Safety and tolerability of thalidomide. Available at: <http:\/\/www.clevelandclinic.org\/myeloma\/safety_of_thalidomide.htm>."},{"key":"10.1016\/j.mehy.2015.05.016_b0120","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in squamous cell carcinoma of the head and neck","author":"Simpson","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.mehy.2015.05.016_b0125","article-title":"Efficacy and safety of sequential use of Everolimus in patients with metastatic renal cell carcinoma previously treated with Bevacizumab with or without Interferon therapy: results from the European AVATOR study","author":"Thiery-Vuillemin","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.mehy.2015.05.016_b0130","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.mehy.2015.05.016_b0135","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/lary.21927","article-title":"The successful management of diffuse lymphangiomatosis using Sirolimus: a case report","volume":"121","author":"Reinglas","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.mehy.2015.05.016_b0140","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/pbc.22766","article-title":"Treatment of childhood kaposiform hemangioendothelioma with Sirolimus","volume":"15","author":"Blatt","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.mehy.2015.05.016_b0145","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/lsm.21141","article-title":"Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration","volume":"43","author":"Nelson","year":"2011","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.mehy.2015.05.016_b0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1582-4934.2005.tb00355.x","article-title":"Matrix metalloproteinases and angiogenesis","volume":"9","author":"Rundhaug","year":"2005","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.mehy.2015.05.016_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-5-1","article-title":"Suppression of MMP-9 by doxycycline in brain arteriovenous malformations","volume":"5","author":"Hashimoto","year":"2005","journal-title":"BMC Neurol"},{"key":"10.1016\/j.mehy.2015.05.016_b0160","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/sj.jcbfm.9600268","article-title":"Dose-response effect of tetracycline on cerebral matrix metalloproteinases-9 after vascular endothelial growth factor hyperstimulation","volume":"26","author":"Lee","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2015.05.016_b0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/SCS.0b013e3181927f1e","article-title":"Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child","volume":"20","author":"Burrows","year":"2009","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.mehy.2015.05.016_b0170","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/STROKEAHA.111.647982","article-title":"Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain","volume":"43","author":"Walker","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2015.05.016_b0175","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.mehy.2012.02.011","article-title":"VEGF target in HHT lung patients: the role of bevacizumab as a possible alternative to embolization","volume":"78","author":"Lacout","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2015.05.016_b0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multi center, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mehy.2015.05.016_b0185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pharmthera.2013.05.001","article-title":"A review of contemporary options for medical management of hemangiomas, other vascular tumors and vascular malformations","volume":"139","author":"Blatt","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.mehy.2015.05.016_b0190","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3109\/09273948.2011.589022","article-title":"Rapid and sustained resolution of serous retinal detachment in Sturge\u2013Weber syndrome after single injection of intravitreal bevacizumab","volume":"19","author":"Shoeibi","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.mehy.2015.05.016_b0195","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2015.05.016_b0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000321801","article-title":"Incidental resolution of a radiation-induced hemangioma of the brain following the use of bevacizumab in a child with recurrent medulloblastoma","volume":"46","author":"Aguilera","year":"2010","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.mehy.2015.05.016_b0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000341075","article-title":"Antiangiogenic treatment for multiple CNS hemangioblastomas","volume":"35","author":"Riklin","year":"2012","journal-title":"Onkologie"},{"key":"10.1016\/j.mehy.2015.05.016_b0210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2415-13-60","article-title":"Mature vessel occlusion after anti-VEGF treatment in a retinal arteriovenous malformation","volume":"13","author":"Chuang","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.mehy.2015.05.016_b0215","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1023\/A:1020923326441","article-title":"Evidence for the causal role of endogenous interferon-alpha\/beta in the regulation of angiogenesis, tumorigenicity and metastasis of cutaneous neoplasms","volume":"19","author":"McCarty","year":"2002","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.mehy.2015.05.016_b0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(89)90694-6","article-title":"Treatment of hemangioendotheliomas with alpha-interferon","volume":"2","author":"Orchard","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2015.05.016_b0225","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archsurg.1990.01410200081012","article-title":"Complex hemangiomas of infants and children: individualized management in 22 cases","volume":"125","author":"Weber","year":"1990","journal-title":"Arch Surg"},{"key":"10.1016\/j.mehy.2015.05.016_b0230","unstructured":"Boon LM, Burrows PE, Paltiel HJ et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. Presented in part as an abstract to the Society of Pediatric Research Meeting in San Diego, Calif., April 1995."},{"key":"10.1016\/j.mehy.2015.05.016_b0235","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08916930903510963","article-title":"Interferon-alpha as angiogenesis inhibitor: learning from tumor models","volume":"43","author":"Indraccolo","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.mehy.2015.05.016_b0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1160\/TH11-11-0809","article-title":"Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia","volume":"108","author":"Albinana","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mehy.2015.05.016_b0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00210-014-0969-1","article-title":"\u03b23-Adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling","volume":"387","author":"Dalmonte","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.mehy.2015.05.016_b0250","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1055\/s-2006-944829","article-title":"Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide","volume":"38","author":"Bauditz","year":"2006","journal-title":"Endoscopy"},{"key":"10.1016\/j.mehy.2015.05.016_b0255","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2011.07.018","article-title":"Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation","volume":"141","author":"Ge","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2015.05.016_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.25422","article-title":"Successful treatment of kaposiform lymphangiomatosis with Sirolimus","author":"Wang","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.mehy.2015.05.016_b0265","first-page":"12","article-title":"Medication-based therapy of infantile hemangioma and lymphatic malformations","volume":"62","author":"Rossler","year":"2014","journal-title":"HNO"},{"key":"10.1016\/j.mehy.2015.05.016_b0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5694\/mja12.11567","article-title":"Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis","volume":"199","author":"Mohammadieh","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.mehy.2015.05.016_b0275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00234-014-1328-0","article-title":"Endovascular treatment of head and neck arteriovenous malformations","volume":"56","author":"Dmytriw","year":"2014","journal-title":"Neuroradiology"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T02:09:16Z","timestamp":1599098956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987715002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0306987715002145"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2015.05.016","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2015.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}